https://www.selleckchem.com/products/cpi-1205.html
The design of small molecules that inhibit disease-relevant proteins represents a longstanding challenge of medicinal chemistry. Here, we describe an approach for encoding this challenge-the inhibition of a human drug target-into a microbial host and using it to guide the discovery and biosynthesis of targeted, biologically active natural products. This approach identified two previously unknown terpenoid inhibitors of protein tyrosine phosphatase 1B (PTP1, an elusive therapeutic target for the treatment of diabetes and cancer. Both
Aimer
Commentaire
Partagez
